Kidney cancer brings questions about the tumour and about the kidneys themselves. You may be weighing surgery, preparing for drug treatment or wondering how eating, activity and daily routines will change after treatment. A useful integrative plan begins with a clear understanding of both the cancer and your kidney function.
This guide is for people exploring kidney cancer support in Vancouver and Metro Vancouver. Dr. Walter Lemmo, ND, is a naturopathic doctor at LEMMO Integrated Cancer Care in Burnaby. Complementary-care discussions should be coordinated with the urologist, oncology team and other clinicians responsible for your cancer treatment and kidney health.
Understanding your type of kidney cancer
Renal cell carcinoma is the most common kidney cancer in adults. Subtypes include clear cell, papillary and chromophobe cancers. Cancer arising in the kidney’s collecting area, called the renal pelvis, may be urothelial cancer and follow a different treatment pathway. The exact name on the pathology report therefore matters. Canadian Cancer Society: types of kidney cancer.
Ask your team to write the diagnosis, subtype and stage in one place. If you have only an imaging report and no tissue diagnosis yet, ask what can be concluded from the scans and whether a biopsy would change the next step. A good consultation should make the remaining uncertainty understandable without turning every unanswered question into a reason to postpone care.
Tests and kidney function
Assessment can include CT or other imaging, urine tests and blood tests. Creatinine and an estimated glomerular filtration rate, or eGFR, help clinicians assess kidney function. Imaging also helps define tumour size, location and possible spread. A biopsy is used in selected circumstances rather than for every kidney mass. Canadian Cancer Society: diagnosing kidney cancer.
Keep recent results with their dates. Ask which numbers need ongoing monitoring, who will order repeat testing and who will interpret a change. If you receive advice from more than one clinic, make sure everyone is using the same current information.
How kidney cancer treatment is selected
For disease confined to the kidney, treatment may involve removal of the tumour with part of the kidney or removal of the whole kidney. Selected patients may be considered for ablation or other approaches. In advanced renal cell cancer, immunotherapy and targeted medicines are important options. Some people at increased risk after surgery may also be offered additional treatment. The choice depends on tumour features, overall health, previous treatment and clinical goals. National Cancer Institute: renal cell cancer treatment.
Ask what each option would mean for you in practical terms. How much recovery time should you plan for? Which appointments are essential? What help might you need at home? If monitoring is recommended, ask for a written schedule and the findings that would prompt treatment. Confirm which therapies or trials are available through your British Columbia cancer team.
Living with one kidney or reduced kidney function
Many people live well with one functioning kidney. Dietary needs depend on how well the remaining kidney tissue works. A person with normal function may have different needs from someone with chronic kidney disease or someone receiving dialysis. Fluid, protein and mineral advice should therefore be individualized with the treating team and a dietitian when appropriate. Canadian Cancer Society: supportive care and kidney health.
Bring conflicting food or hydration advice to an appointment rather than trying to combine it yourself. A useful question is: “Does this advice apply to my present kidney function and treatment, and what result are we monitoring?” Ask for a workable plan that reflects your appetite, cultural food preferences, budget and usual routine. Avoid turning a general online checklist into a set of restrictions without a reason for each one.
Exploring alternative kidney cancer treatments in Vancouver
Searching for alternative kidney cancer treatments may reflect a wish to do more for yourself during treatment. There is no established special diet, vitamin or supplement programme that can be relied on to cure cancer or prevent its return. NCI: diets, supplements and cancer.
Complementary support should have a defined purpose alongside your oncology plan: for example, discussing sleep difficulties, the practical effects of fatigue or questions about maintaining food intake. Ask Dr. Lemmo to explain the aim of any proposed recommendation, its evidence and how it fits your kidney function and prescribed care. Feeling actively involved in decisions does not require adding a product at every visit.
Review supplements before adding them
Supplements, herbs and some foods can change the way anticancer medicines are processed. Provide your oncology pharmacist and other treating clinicians with the full product names, ingredients and doses before starting them. “Natural” is not enough information to establish compatibility with treatment. NCI: cancer therapy interactions with foods and supplements.
Ask who will review kidney-related precautions and whether the plan changes before surgery, a scan or a new drug. Keep one shared list, including products you take occasionally. If someone recommends stopping a prescribed medicine, confirm that decision with its prescriber.
Making symptom conversations more useful
A short symptom record can make an appointment easier to use. Note what changed, when it began, how it affects eating or activity and whether it coincided with a treatment change. Bring the record to the team responsible for your cancer therapy rather than assuming every difficulty can be addressed through a wellness plan.
Immunotherapy can cause inflammation and other adverse effects, sometimes after treatment has ended. Follow your oncology team’s instructions for reporting new symptoms. NCI: immunotherapy side effects.
Follow-up, recovery and longer-term planning
Follow-up after kidney cancer can include examination, blood testing and imaging, with the schedule tailored to the cancer and treatment. Kidney function may also require monitoring. Report new or persistent symptoms instead of waiting for the next planned review. Canadian Cancer Society: kidney cancer follow-up.
Use follow-up appointments to clarify both medical and practical responsibilities. Who is monitoring kidney function? Who renews medications? Who can help with work forms or recovery concerns? When a treatment course ends, ask for a concise written account of what you received and what comes next. This becomes particularly helpful when you are moving between hospital, family practice and supportive-care appointments.
Preparing for a consultation with Dr. Lemmo
Bring the pathology report if available, imaging summaries, recent kidney function tests, surgical information, oncology notes and a medication and supplement list. Write down the concern that has the greatest effect on an ordinary day.
- What is the specific goal of a proposed complementary approach?
- Does it fit my current kidney function and cancer treatment?
- Which clinician should review it before I start?
- How will we measure benefit and identify side effects?
- What are the total costs, visit commitments and reasons to stop?
Kidney cancer support in Burnaby, serving Vancouver
LEMMO Integrated Cancer Care is at Suite 205, 3900 Hastings Street, Burnaby, serving Vancouver and Metro Vancouver. Read about Dr. Walter Lemmo, ND, explore integrative cancer care and review new-patient information. Contact the clinic to discuss an appointment.
This information is educational and does not replace individualized advice from your cancer and kidney-care teams.
Sources and further reading
- Canadian Cancer Society — Cancerous tumours of the kidney
- Canadian Cancer Society — Diagnosis of kidney cancer
- National Cancer Institute — Renal Cell Cancer Treatment (PDQ), patient version
- Canadian Cancer Society — Supportive care for kidney cancer
- National Cancer Institute — Diets, supplements and cancer
- National Cancer Institute — Cancer therapy interactions with foods and dietary supplements
- National Cancer Institute — Immunotherapy side effects
- Canadian Cancer Society — Follow-up after treatment for kidney cancer
